Published in Lancet Neurol on October 01, 2002
Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev (2010) 11.25
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci (2010) 5.27
Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch (2010) 2.83
NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol (2008) 2.13
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int (2007) 2.11
Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci (2006) 1.94
The dichotomy of NMDA receptor signaling. Neuroscientist (2007) 1.61
Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J Neurosci (2008) 1.58
Controversies and evolving new mechanisms in subarachnoid hemorrhage. Prog Neurobiol (2013) 1.54
Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans (2009) 1.50
Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury. Crit Care (2004) 1.49
Blood-brain barrier pathophysiology in traumatic brain injury. Transl Stroke Res (2011) 1.45
Degeneration and repair in central nervous system disease. Nat Med (2010) 1.42
Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels. J Biol Chem (2010) 1.38
Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nat Med (2009) 1.36
In developing hippocampal neurons, NR2B-containing N-methyl-D-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience (2008) 1.36
Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. J Neurotrauma (2009) 1.34
Calcium-dependent mitochondrial function and dysfunction in neurons. FEBS J (2010) 1.25
Re-orientation of clinical research in traumatic brain injury: report of an international workshop on comparative effectiveness research. J Neurotrauma (2011) 1.23
Compartmentalized NMDA receptor signalling to survival and death. J Physiol (2007) 1.21
TRPMs and neuronal cell death. Pflugers Arch (2005) 1.19
Ca2+ -permeable acid-sensing ion channels and ischemic brain injury. J Membr Biol (2006) 1.19
ASIC1a-specific modulation of acid-sensing ion channels in mouse cortical neurons by redox reagents. J Neurosci (2006) 1.19
Pro-survival signalling from the NMDA receptor. Biochem Soc Trans (2006) 1.17
Neuronal gap junction coupling is regulated by glutamate and plays critical role in cell death during neuronal injury. J Neurosci (2012) 1.16
Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2). J Biol Chem (2011) 1.15
Neuronal gap junctions: making and breaking connections during development and injury. Trends Neurosci (2012) 1.13
High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia (2013) 1.10
Computational studies of NMDA receptors: differential effects of neuronal activity on efficacy of competitive and non-competitive antagonists. Open Access Bioinformatics (2010) 1.07
Oligovascular signaling in white matter stroke. Biol Pharm Bull (2009) 1.06
Neuroprotection for stroke: current status and future perspectives. Int J Mol Sci (2012) 1.04
Pathophysiologic cascades in ischemic stroke. Int J Stroke (2012) 1.03
Neuroprotection in the newborn infant. Clin Perinatol (2009) 0.99
Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study. Psychiatry Investig (2012) 0.98
Activated protein C is neuroprotective and mediates new blood vessel formation and neurogenesis after controlled cortical impact. Neurosurgery (2010) 0.98
Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases. CNS Neurol Disord Drug Targets (2013) 0.98
Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke. PLoS One (2011) 0.96
Acid-sensing ion channels in acidosis-induced injury of human brain neurons. J Cereb Blood Flow Metab (2010) 0.96
Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema. Transl Stroke Res (2013) 0.96
Blood glutamate scavenging: insight into neuroprotection. Int J Mol Sci (2012) 0.95
Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice. Stroke (2014) 0.95
Pharmacologic neuroprotective strategies in neonatal brain injury. Clin Perinatol (2013) 0.95
Mild Hypothermia Suppresses Calcium-Sensing Receptor (CaSR) Induction Following Forebrain Ischemia While Increasing GABA-B Receptor 1 (GABA-B-R1) Expression. Transl Stroke Res (2011) 0.93
Endogenous GABA(A) and GABA(B) receptor-mediated electrical suppression is critical to neuronal anoxia tolerance. Proc Natl Acad Sci U S A (2011) 0.93
The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse. Front Cell Neurosci (2014) 0.92
Influence of alcohol on mortality in traumatic brain injury. J Am Coll Surg (2010) 0.92
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Invest New Drugs (2012) 0.91
Therapeutic use of PDZ protein-protein interaction antagonism. Drug News Perspect (2008) 0.91
Activation of NR2A receptors induces ischemic tolerance through CREB signaling. J Cereb Blood Flow Metab (2010) 0.90
Calcium-sensing receptor (CaSR) as a novel target for ischemic neuroprotection. Ann Clin Transl Neurol (2014) 0.90
Experimental models for analysis of oligodendrocyte pathophysiology in stroke. Exp Transl Stroke Med (2009) 0.89
The transcriptome of cerebral ischemia. Brain Res Bull (2012) 0.89
Antagonism of purinergic signalling improves recovery from traumatic brain injury. Brain (2013) 0.89
Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction. Acta Pharmacol Sin (2012) 0.89
Altered calcium signaling following traumatic brain injury. Front Pharmacol (2012) 0.89
TRP channels: sensors and transducers of gasotransmitter signals. Front Physiol (2012) 0.88
Increasing small conductance Ca2+-activated potassium channel activity reverses ischemia-induced impairment of long-term potentiation. Eur J Neurosci (2014) 0.88
Novel NMDA receptor modulators: an update. Expert Opin Ther Pat (2012) 0.87
Inhibition of a SNARE-sensitive pathway in astrocytes attenuates damage following stroke. J Neurosci (2013) 0.87
Why have neuro-protectants failed?: lessons learned from stroke trials. J Neurol (2005) 0.87
Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders. Aging Dis (2016) 0.86
The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors. Curr Opin Investig Drugs (2005) 0.86
Neuronal gap junction coupling as the primary determinant of the extent of glutamate-mediated excitotoxicity. J Neural Transm (Vienna) (2013) 0.86
Emerging therapies in traumatic brain injury. Semin Neurol (2015) 0.86
Activation of a novel injury-induced calcium-permeable channel that plays a key role in causing extended neuronal depolarization and initiating neuronal death in excitotoxic neuronal injury. J Pharmacol Exp Ther (2007) 0.85
Mechanisms of neurovascular dysfunction in acute ischemic brain. Curr Med Chem (2014) 0.85
Traumatic brain injury and NADPH oxidase: a deep relationship. Oxid Med Cell Longev (2015) 0.85
Main path and byways: non-vesicular glutamate release by system xc (-) as an important modifier of glutamatergic neurotransmission. J Neurochem (2015) 0.85
Brain to blood glutamate scavenging as a novel therapeutic modality: a review. J Neural Transm (Vienna) (2014) 0.84
Neuronal necrosis is regulated by a conserved chromatin-modifying cascade. Proc Natl Acad Sci U S A (2014) 0.84
The effect of treadmill training pre-exercise on glutamate receptor expression in rats after cerebral ischemia. Int J Mol Sci (2010) 0.84
Novel model for the mechanisms of glutamate-dependent excitotoxicity: role of neuronal gap junctions. Brain Res (2012) 0.84
Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk. Br J Pharmacol (2004) 0.84
Death of Neurons following Injury Requires Conductive Neuronal Gap Junction Channels but Not a Specific Connexin. PLoS One (2015) 0.84
The role of ASICS in cerebral ischemia. Wiley Interdiscip Rev Membr Transp Signal (2012) 0.84
The dichotomy of memantine treatment for ischemic stroke: dose-dependent protective and detrimental effects. J Cereb Blood Flow Metab (2014) 0.83
Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death. EMBO J (2014) 0.83
Local administration of AAV-BDNF to subventricular zone induces functional recovery in stroke rats. PLoS One (2013) 0.83
Mitochondrial ATP-sensitive K+ channels regulate NMDAR activity in the cortex of the anoxic western painted turtle. J Physiol (2007) 0.83
To look beyond vasospasm in aneurysmal subarachnoid haemorrhage. Biomed Res Int (2014) 0.83
Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats. Front Behav Neurosci (2014) 0.83
The expression pattern of ADP-ribosyltransferase 3 in rat traumatic brain injury. J Mol Histol (2011) 0.82
NMDA receptor-dependent glutamate excitotoxicity in human embryonic stem cell-derived neurons. Neurosci Lett (2013) 0.82
Death Associated Protein Kinase (DAPK) -mediated neurodegenerative mechanisms in nematode excitotoxicity. BMC Neurosci (2015) 0.82
Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation. Front Cell Neurosci (2015) 0.81
Physical and functional interaction of NCX1 and EAAC1 transporters leading to glutamate-enhanced ATP production in brain mitochondria. PLoS One (2012) 0.81
Neuroprotection associated with alternative splicing of NMDA receptors in rat cortical neurons. Br J Pharmacol (2006) 0.81
In vivo 2D magnetic resonance spectroscopy of small animals. MAGMA (2004) 0.80
Calcium-permeable ion channels involved in glutamate receptor-independent ischemic brain injury. Acta Pharmacol Sin (2011) 0.80
Synaptically-competent neurons derived from canine embryonic stem cells by lineage selection with EGF and Noggin. PLoS One (2011) 0.79
Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides. Front Cell Neurosci (2015) 0.79
Is it time to conclude that NMDA antagonists have failed? Lancet Neurol (2003) 0.79
Restoring neuroprotection through a new preclinical paradigm: translational success for NA-1 in stroke therapy. Acta Pharmacol Sin (2012) 0.79
Glycine-induced neurotoxicity in organotypic hippocampal slice cultures. Exp Brain Res (2004) 0.79
Selective regulation of NR2B by protein phosphatase-1 for the control of the NMDA receptor in neuroprotection. PLoS One (2012) 0.79
Administration of memantine during withdrawal mitigates overactivity and spatial learning impairments associated with neonatal alcohol exposure in rats. Alcohol Clin Exp Res (2014) 0.79
The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage. Neurotherapeutics (2012) 0.79
Region-specific role for GluN2B-containing NMDA receptors in injury to Purkinje cells and CA1 neurons following global cerebral ischemia. Neuroscience (2014) 0.78
Acacetin inhibits glutamate release and prevents kainic acid-induced neurotoxicity in rats. PLoS One (2014) 0.78
Posttraumatic secondary brain insults exacerbates neuronal injury by altering metabotropic glutamate receptors. BMC Neurosci (2007) 0.78
Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol (2008) 2.46
Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol (2009) 1.31
NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci U S A (2005) 1.30
Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol (2007) 1.26
Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proc Natl Acad Sci U S A (2005) 1.06
Antiepileptic drugs and brain development. Epilepsy Res (2009) 1.04
Multiple sclerosis and glutamate. Ann N Y Acad Sci (2003) 1.03
Glutamate antagonists limit tumor growth. Biochem Pharmacol (2002) 0.95
Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells. Cancer Biol Ther (2008) 0.90
Mechanisms of disease: motoneuron disease aggravated by transgenic expression of a functionally modified AMPA receptor subunit. Ann N Y Acad Sci (2005) 0.84
Glutamate receptors in laryngeal cancer cells. Anticancer Res (2011) 0.84
AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growth. Cancer Biol Ther (2007) 0.83
Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels. Am J Physiol Endocrinol Metab (2011) 0.81
Tolerance to and Dependence on Alprazolam are Due to Changes in GABAa Receptor Function and Are Independent of Exposure to Experimental Set-up. Restor Neurol Neurosci (1998) 0.75